FDA Clearance Tracker · DEN150009
B.R.A.H.M.S PCT sensitive KRYPTOR
Last checked: Nov 20, 2026Latest source record: Feb 20, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Feb 20, 2016
De Novo granted
Time to decision
353 days
Received Mar 4, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN150009
- Device name
- B.R.A.H.M.S PCT sensitive KRYPTOR
- Applicant
- Brahms GmbH
- Applicant location
- Henningsdorf, DE
- Received
- Mar 4, 2015
- Decided
- Feb 20, 2016
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3215
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN150009
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Brahms GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- B·R·A·H·M·S sFlt-1/ PlGF KRYPTOR Test SystemNew device typeBreakthroughDe Novo
DEN220027 · Decided May 18, 2023 · 381 days after receipt
Device type: Prognostic Test For Development Or Progression Of Preeclampsia (QWH) · Laboratory Medicine & Pathology
K171338 · Decided May 31, 2017 · 23 days after receipt
Device type: Procalcitonin Assay (PRI) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.